ArticleBioprocess and biosystems engineering2026
Liquid fermentation technology optimization of nattokinase: from Lab-scale to Pilot-scale.
Article in Bioprocess and biosystems engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Nattokinase is a high-valued functional component produced during natto fermentation, and both its activity level and production yield are of significant importance for industrial applications. This study aimed to optimize and scale up the fermentation process for nattokinase production. We first optimized the liquid fermentation process for nattokinase through single-factor and response surface methodology (RSM) experiments, determining the optimal medium composition. Under the optimized conditions, a nattokinase activity of 4257 IU/mL was attained in shake-flask fermentation. Subsequently, a fed-batch cultivation process was employed in pilot-scale experiments. In a 20 L fermenter, dynamic control of oxygen supply and optimization of feed addition timing were implemented, resulting in an increase of the nattokinase activity to 23,074 IU/mL. When scaling up to a 200 L fermenter, an innovative strategy was adopted to overcome the oxygen transfer efficiency bottleneck. This approach involved low-speed startup, stirring-dominated oxygen control, and strict ventilation restrictions. As a result, the nattokinase activity reached 21,312 IU/mL, equivalent to 92.36% of the activity achieved in the 20 L fermenter. This optimized and scalable process provides a stable and controllable technical solution for pilot-scale upscaling, and establishes a strong foundation for large-scale industrial production of nattokinase.
Indexed as
Identifiers
41454164What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.